Navigation Links
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Date:10/29/2009

Amicus Therapeutics, Inc. Reconciliation of GAAP to non-GAAP Measures for the Statement of Operations Information for Three Months Ended September 30, 2009 (Unaudited) (In thousands, except share and per share amounts) Stock GAAP as Non-GAAP Compensation Reported -------- -------------- ------------ Income Statement Classifications: Revenue $4,913 $4,913 Research and development (11,780) $(829) (12,609) General and administrative (4,075) (1,142) (5,217) Depreciation and amortization (561) (561) Interest income 129 129 Interest expense (84) (84) --- ------- --- Summary: Net loss: $(11,458) $(1,971) $(13,429) -------- ------- -------- Net loss per share - basic and diluted: $(0.51) $(0.09) $(0.59) ====== ====== ====== Weighted average number of shares outstanding: 22,621,513 22,621,513 ========== ========== Table 3 Amicus Therapeutics, Inc. Reconciliation of GAAP to non-GAAP Measures for the Statement of Operations Information for Three Months Ended September 30, 2008 (Unaudited) (In thousands, except share and per shar
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014  ARCH Venture Partners, one of ... the development of seed and early-stage advanced technology ... closed with more than $400 million in subscriptions. ... subscription target by more than $150 million. ... strength and potential of our approach to finding ...
(Date:8/27/2014)... After the boom of the energy ... beverage craze is going to be the stress relief ... use Stress Relief energy pattern which can be applied ... a beverage, including minerals, herbs and liquids. Stress Relief ... power into rapid recovery and helping to adapt more ...
(Date:8/27/2014)... 2014 Budding Biomedical Scientists , ... School participated in the Scientific Enrichment and ... School of Medicine . , The ... professional experience in the sciences and brings them ... and students for both academic and career mentoring. ...
(Date:8/26/2014)... 2014 An analysis by Replikins, Ltd. of ... Mers CoV virus strains has revealed extensive conservation ... This conservation and sharing of specific Replikin gene structures ... candidate, as it did for the H5N1 influenza vaccine ... have been found to be effective (1,2). ...
Breaking Biology Technology:Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4Students at Cleveland's University School Conduct Biomedical Research at Case Western Reserve University’s School of Medicine 2
... Gov. Jim Doyle has announced that Berbee ... Fitchburg Technology Campus, will receive $250,000 in state Technology Zone ... in a new 43,250-square-foot office building and a 51,500-square-foot data ... the Fitchburg Technology Campus. , ,The project is expected ...
... Madison company that is developing drugs to protect cancer ... has closed on a Series A Preferred Stock financing ... , ProCertus BioPharm , an oncology-based pharmaceutical company, will ... patients to demonstrate proof-of-concept in humans for its chemo- ...
... a patient presents to a doctor, many assessments have to ... of what is unglamorously called managing the patient. , ,During ... would have us believe, one of the most important judgment ... or not. This is not in the sense that ...
Cached Biology Technology:ProCertus BioPharm secures $2.3M in financing 2ProCertus BioPharm secures $2.3M in financing 3Barriers will not stop convergence of medical technologies 2Barriers will not stop convergence of medical technologies 3Barriers will not stop convergence of medical technologies 4Barriers will not stop convergence of medical technologies 5Barriers will not stop convergence of medical technologies 6Barriers will not stop convergence of medical technologies 7
(Date:8/27/2014)... when it is related to ability that we already ... new melody more easily than learning how to hit ... for the Neural Basis of Cognition (CNBC)a joint program ... discovered a fundamental constraint in the brain that may ... in the Aug. 28, 2014, issue of Nature ...
(Date:8/27/2014)... University of Utah biologist agan Sekercioglu, who campaigns to ... nation,s highest science prize, which is similar to the ... five researchers picked for 2014 the top awards by ... Three researchers won the Science Award and two ... equivalent to the Science Award but for scientists who ...
(Date:8/27/2014)... by the Volunteer Wildfire Services of South Africa as ... warned residents in certain parts of the province on ... A high veld fire danger rating is expected in ... Great Kei and Mnquma area. Strong winds often ... thunderstorms bring lightning strikes and subsequent fire and the ...
Breaking Biology News(10 mins):Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3University of Utah biologist wins Turkey's top science prize 2
... of questions, but sometimes traditional techniques are superior. Authorities ... when they relied upon statistical data to monitor moose ... indigenous group of people living in the James Bay ... have lived in harmony with their environment. They hunt ...
... southern limit of permanently frozen ground, or permafrost, is now ... in the James Bay region, according to two researchers from ... issue of the scientific journal Permafrost and Periglacial Processes ... trend continues, permafrost in the region will completely disappear in ...
... This release is available in Spanish . ... reliably mark termites and other insects over vast acreage so ... the previous methodand more affordable. That,s according to ... agency,s U.S. Arid-Land Agricultural Research Center in Maricopa, Ariz., and ...
Cached Biology News:Listen to the natives for better moose monitoring 2Permafrost line recedes 130 km in 50 years 2New assay helps track termites and other insects 2
Recombinant Rat Leptin, Ultra Pure...
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
Bethyl Laboratories packages antibodies, conjugates and calibrators to provide quantitative ELISA kits. Each kit contains the following components, sufficient for 1000 single well assays....
quantitation of phosphatase activity, evaluation of hits and leads from HTS...
Biology Products: